FUS and breast cancer: Therefore, our research revealed for the first time the inhibition of selective autophagy of afadin driven by a positive feedback loop comprising circROBO1/KLF5/FUS, which promoted BC-derived liver metastasis progression and provided novel prognostic biomarkers and antimetastatic therapeutic targets for BC patients in clinical practice.